Integra LifeSciences Holdings Corporation
IART
$13.57
$0.564.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -171.97% | -110.25% | -106.49% | -81.99% | -76.59% |
| Total Depreciation and Amortization | 19.99% | 14.07% | 4.23% | 12.45% | 2.69% |
| Total Amortization of Deferred Charges | -1.62% | -9.26% | -12.56% | -15.65% | -19.10% |
| Total Other Non-Cash Items | -54.23% | -13.54% | 7.56% | 6,499.72% | 37,849.18% |
| Change in Net Operating Assets | 48.15% | 61.99% | 89.03% | 8.21% | -19.23% |
| Cash from Operations | -20.98% | -7.55% | -17.50% | -31.91% | -47.40% |
| Capital Expenditure | -71.76% | -56.16% | -74.96% | -56.60% | -46.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -447.47% | -447.47% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.83% | 68.59% | -1,260.40% | -- | -1,440.66% |
| Cash from Investing | -177.27% | -314.97% | -383.59% | -536.80% | -130.93% |
| Total Debt Issued | -67.57% | 194.67% | 205.93% | 1,657.81% | 1,223.43% |
| Total Debt Repaid | -65.29% | -69.20% | 11.26% | -21.01% | 24.06% |
| Issuance of Common Stock | -88.59% | 48.20% | -16.85% | -0.44% | 28.04% |
| Repurchase of Common Stock | 57.29% | 80.07% | 80.88% | -14.02% | 24.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,724.92% | -51.33% | -61.31% | -61.31% | 96.03% |
| Cash from Financing | -129.32% | 203.45% | 174.24% | 174.76% | 203.65% |
| Foreign Exchange rate Adjustments | 250.57% | -266.21% | 24.99% | -250.51% | 69.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -223.99% | 83.34% | 75.41% | 31.90% | 385.32% |